Reference Tracing and Source Attribution for Phase I Clinical Pharmacovigilance

Phase I clinical trial pharmacovigilance data originates from clinical trial protocols, informed consent forms, case report forms (CRFs), adverse

Data Characteristics for This Category

Phase I clinical trial pharmacovigilance data originates from clinical trial protocols, informed consent forms, case report forms (CRFs), adverse event (AE) or serious adverse event (SAE) reports, laboratory test results, medical imaging reports, and subject visit records. This data exists as a mix of structured (e.g., field data in CRFs) and unstructured (e.g., handwritten doctor's notes, imaging report text) formats. Data updates frequently, especially during the trial, with AE/SAE reports potentially generated in real time. Documents often contain extensive medical terminology, abbreviations, and specific coding systems (e.g., MedDRA). Their structure strictly adheres to ICH GCP and regulatory requirements from various countries, such as CIOMS I forms or FDA 3500A forms. Key fields include subject identifier, drug name, dosage, administration route, adverse event description, onset time, severity, outcome, and assessment of causality with the investigational drug.

Constraints Imposed by These Characteristics on "Reference Tracing and Source Attribution"

The real-time nature and complexity of Phase I clinical trial data place high demands on reference tracing and source attribution. The immediacy of adverse event reports requires the knowledge base to index and update rapidly, ensuring the timeliness of citations. Professional terminology and coding systems within documents, such as MedDRA codes, necessitate accurate entity recognition and matching capabilities from the RAG system to avoid semantic deviations. Extracting key information from unstructured text is challenging, requiring high-quality chunking and vectorization. Furthermore, strict compliance requirements, such as ICH GCP, mean all references must be traceable to the original document and page number to support audits and regulatory reviews. The accuracy and completeness of reference sources directly impact the reliability of drug safety evaluations. Garbled text issues often relate to inconsistent character encoding, especially when processing multi-source data, where incorrect UTF-8 parsing can lead to text parsing failures.

Configuration Settings

Configuration ItemSuggested ValueRationale for This Value
Chunk Length500–800 charactersBalances the completeness of adverse event descriptions with model processing efficiency, preventing truncation of key information.
Recall Count8–12 itemsEnsures coverage of multiple potentially relevant adverse event reports or study documents, improving recall rate.
Similarity Threshold0.75–0.85Balances recall precision with generalization ability, reducing false positives and focusing on highly relevant medical text.
Rerank Return Count3–5 itemsFurther refines results, providing the most relevant and highly credible references for manual review.
PARSE_FILE_TIMEOUT_SECONDS300 secondsAddresses the time required to parse complex PDFs or large CSV files that may be present in Phase I clinical reports.
UPLOAD_FILE_MAX_SIZE200 MBAccommodates the file size of clinical reports that may contain numerous images or embedded data.

Three Common Mistakes

  • Model output references do not match the original content. This often results from overly large knowledge base chunk granularity or semantic understanding deviations.
  • The cited content contains numerous garbled characters. This occurs when the file encoding is not correctly identified or converted during upload, for example, parsing a GBK encoded file as UTF-8.
  • The answer does not clearly indicate the specific paragraph or page number of the reference, making traceability difficult and failing to meet regulatory audit requirements.

How to Confirm Proper Configuration

  • Randomly select 10 Phase I clinical adverse event reports, upload them to the knowledge base, and check if all key information is correctly indexed and retrievable.
  • For known adverse event queries, verify that the model's output references accurately pinpoint specific paragraphs in the original report and confirm content consistency.
  • Upload test files containing special characters and multiple languages (if applicable) to confirm that knowledge base content parsing is free of garbled text and can be cited normally.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.